QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sp-500-falls-below-5500-points-on-cooling-jobs-data-tesla-leads-tech-gains-natural-gas-spikes-whats-driving-markets-thursday

Signs of a cooling labor market last month pushed major U.S. stock averages lower on Thursday, ahead of the highly anticipated ...

 baird-maintains-outperform-on-copart-lowers-price-target-to-56

Baird analyst Craig Kennison maintains Copart (NASDAQ:CPRT) with a Outperform and lowers the price target from $58 to $56.

 copart-shares-fall-after-worse-than-expected-q4-results-details

Copart shares are trading lower after the company reported its fourth-quarter financial results after Wednesday's closing b...

 copart-q4-2024-gaap-eps-033-misses-036-estimate-sales-1068b-miss-1081b-estimate

Copart (NASDAQ:CPRT) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.36 by 8.3...

 stocks-rebound-chipmakers-halt-bloodbath-as-traders-upgrade-rate-cut-wagers-tesla-rises-dollar-tree-in-free-fall-whats-driving-markets-wednesday

Wall Street traded slightly higher on Wednesday, rebounding after the sharp sell-off a day earlier that saw chipmakers tumble, ...

 copart-q3-2024-gaap-eps-039-misses-041-estimate-sales-1127b-beat-1105b-estimate

Copart (NASDAQ:CPRT) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.41 by 4.8...

 dow-jones-hits-40000-chinese-tech-stocks-jump-to-15-month-highs-bloodbath-on-meme-stocks-whats-driving-markets-thursday

U.S. major stock indices climbed higher on Thursday morning, with the Dow Jones Industrial Average achieving a historic milesto...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION